Drug Profile
Research programme: Pim protein kinase inhibitors - Vortex Biotechnology
Alternative Names: SMI-4aLatest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Vortex Biotechnology
- Class Benzylidene compounds; Small molecules; Thiazolidinediones
- Mechanism of Action Protein-serine-threonine kinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Haematological malignancies
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Haematological-malignancies in USA